Aurinia Pharmaceuticals (AUPH) Q2 Earnings and Revenues Beat Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of$ 0.01 per share. This compares to loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this biotechnology company would post a loss of$ 0.17 per share when it actually produced a loss of $0.03, delivering a surprise of 82.35%.Over the last four quarters, ...